Shed vs TMates: Coaching, Price, and Access Compared
Shed vs TMates quickly breaks down to a choice between integrated coaching plus name-brand and compounded GLP-1 options at Shed and a flat, dose-stable compounded semaglutide program with 24/7 U.S. doctor access at TMates. Early verdict: pick Shed if you want coaching and choice of name-brand or compounded medication; pick TMates if you prioritize a flat $199/month price and always-on physician access.
Start Shed 2-minute assessment
How they differ at a glance
The most distinctive differences between Shed and TMates are medication variety, pricing model, clinical access and support, U.S. formulation and coverage, and speed of initial eligibility screening. Each provider prescribes compounded medications with the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Key comparison table
| Criteria | Shed | TMates |
|---|---|---|
| Medication options | Name-brand and compounded GLP-1 options | Compounded semaglutide only; limited public detail on tirzepatide |
| Starting price | Compounded semaglutide starting at $199/month; compounded tirzepatide starting at $299/month; 10% off your first month | Flat $199/month at every dose, no step-up fees |
| Clinical support | Continuous coaching integrated into treatment | 24/7 access to U.S.-based doctors and virtual check-ins |
| Eligibility and approval | 2-minute approval assessment; clinician review required before prescription | Provider-reviewed, availability based on medical eligibility |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
1. Medication variety and regulatory status
Shed offers both FDA-approved name-brand GLP-1 medications and compounded alternatives, letting patients choose based on budget and preference. TMates focuses on clinically dosed compounded semaglutide formulated in U.S. facilities and does not publish branded Ozempic, Wegovy, or Zepbound as options. Both platforms include the regulatory qualifier that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Explore Shed name-brand and compounded options
2. Pricing model and transparency
TMates advertises a flat $199/month price that stays the same at every dose with no step-up fees, which helps patients budget through titration. Shed publishes compounded starting prices “starting at $199/month” for semaglutide and “starting at $299/month” for tirzepatide and includes a limited time 10% off your first month. Shed does not publish a single standard price for every plan because coaching is bundled and patients receive a personalized quote after intake.
3. Clinical access and ongoing support
Shed integrates continuous coaching into treatment so coaching is part of the program rather than an add-on. TMates emphasizes 24/7 access to U.S.-based doctors across all 50 states and regular virtual check-ins for medical oversight. If you want behavioral coaching paired with medication, the evidence supports Shed. If you want round the clock physician availability, TMates highlights that support model.
Get TMates flat pricing and 24/7 doctor access
4. Speed, eligibility, and logistics
Shed uses a 2-minute online assessment to check eligibility quickly and then requires a clinician review before issuing prescriptions. TMates provides provider review and notes availability is based on medical eligibility, with medications formulated in U.S.-based facilities and free shipping reported. Both require clinician review and both ship medication once prescriptions are finalized.
Regulatory and evidence disclaimers
Both providers state that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality. Shed also highlights that name-brand medications provide regulatory assurance at a higher cost. Clinical trial outcomes for branded products are referenced by Shed with qualifiers and a note to refer to Terms and Conditions; results may vary.
Final thoughts on Shed vs TMates
Summing up Shed vs TMates: Shed stands out for offering both name-brand and compounded GLP-1 options plus integrated, continuous coaching and a quick 2-minute eligibility assessment with 10% off your first month. TMates stands out for a transparent flat $199/month pricing at every dose, 24/7 U.S. doctor access, and medications formulated in U.S.-based facilities. Both note that compounded medications are not FDA-approved.
Begin Shed intake and coaching
Choose based on what matters most
Choose Shed if you want the option of FDA-approved name-brand GLP-1 or compounded alternatives, integrated continuous coaching, and a rapid 2-minute approval assessment with 10% off your first month. Choose TMates if you prefer a flat $199/month price that does not increase with dose, 24/7 access to U.S.-based doctors, and U.S. formulated compounded semaglutide.